反应详情

N-(2-t-butoxycarbonylaminophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide (400 mg, 0.913 mmol; prepared as described in international patent publication number wo03/087057, method 13, page 60), 2-bromonicotinonitrile (167 mg, 0.913 mmol), tetrakis(triphenylphosphine)palladium[0] (50 mg, 0.043 mmol), 1,2-dimethoxyethane (4 ml) and a saturated aqueous solution of sodium hydrogen carbonate (2 ml) were stirred at 100° c. under an atmosphere of nitrogen in a microwave for 130 mins. the mixture was allowed to cool before being partitioned between dichloromethane and water. the organics were separated, dried over sodium sulfate, filtered and evaporated. the crude product was purified by chromatography on silica eluting with 60:40 ethyl acetate: isohexane to afford the title compound as a white solid (214 mg, 57%); nmr spectrum: (dmso-d6) 1.45 (s, 9h), 7.18 (m, 2h), 7.57 (m, 1h), 7.66 (dd, 1h), 8.01 (d, 2h), 8.13 (d, 2h), 8.47 (dd, 1h), 8.73 (s, 1h), 8.98 (d, 1h), 9.97 (s, 1h); mass spectrum: m+h+415.

1. temperatureto cool
2. custombefore being partitioned between dichloromethane and water
3. customthe organics were separated
4. dry with materialdried over sodium sulfate
5. filtrationfiltered
6. customevaporated
7. customthe crude product was purified by chromatography on silica eluting with 60:40 ethyl acetate